Evidence map›Paper›PMID 33375172›Full record

ArticleVaccines2020

Sustained Vaccination Coverage during the Coronavirus Disease 2019 Epidemic in the Republic of Korea.

Jeong Hee Yu, Hang Jin Jeong, Seon Ju Kim, Jae Young Lee, Young June Choe, Eun Hwa Choi, En Hi Cho

Abstract read
In one paragraph

Article in Vaccines, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jeong Hee YuDivision of National Immunization Program and Vaccine-Preventable Disease Control, Korea Disease Control and Prevention Agency, Cheongju 28159, Korea.
Hang Jin JeongDivision of National Immunization Program and Vaccine-Preventable Disease Control, Korea Disease Control and Prevention Agency, Cheongju 28159, Korea.
Seon Ju KimDivision of National Immunization Program and Vaccine-Preventable Disease Control, Korea Disease Control and Prevention Agency, Cheongju 28159, Korea.
Jae Young LeeDivision of National Immunization Program and Vaccine-Preventable Disease Control, Korea Disease Control and Prevention Agency, Cheongju 28159, Korea.
Young June ChoeDepartment of Social and Preventive Medicine, Hallym University College of Medicine, Chuncheon 24252, Korea.
Eun Hwa ChoiDepartment of Pediatrics, Seoul National University College of Medicine, Seoul 03080, Korea.
En Hi ChoDivision of National Immunization Program and Vaccine-Preventable Disease Control, Korea Disease Control and Prevention Agency, Cheongju 28159, Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Amid the COVID-19 pandemic, vaccination coverage may decline due to limited accessibility to healthcare. We assessed the impact of the COVID-19 pandemic on vaccination coverage and the incidence of vaccine-preventable diseases (VPDs) in the Republic of Korea. National vaccination coverage of 10 essential vaccines administered to children between January-June 2019 and January-June 2020 was analyzed. The national incidence of selected VPDs was compared for the corresponding periods. During the COVID-19 outbreak, the vaccination rate in children aged 0-35 months in Korea did not decrease significantly, whereas the vaccination rate for children aged 4-6 years decreased by 1.4-1.9%. The overall incidence of VPDs decreased by 10-50% between 2019 and 2020, especially with varicella. Thus, the COVID-19 pandemic did not result in a decrease in vaccination coverage among Korean children, which prevented a surge in VPD incidence. Maintaining essential vaccination coverage without interruption is important during the response to the COVID-19 pandemic.

Indexed as

coronavirusCOVID-19SARS-CoV-2vaccinationvaccine coveragevaccine-preventable disease

Identifiers

PMID33375172
PMCPMC7822189

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.